Sector consensus NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.28 USD | -4.00% | -9.17% | -11.58% |
Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
36.71 | +34.12% | 7 | |||||||
262.93 | +6.48% | 15 | |||||||
178.52 | +7.82% | 8 | |||||||
45.99 | +34.47% | 4 | |||||||
74.12 | -6.58% | 10 | |||||||
221.11 | +18.21% | 9 | |||||||
394.03 | +16.90% | 3 | |||||||
3,346.00 | +32.49% | 15 | |||||||
- | - | - | - | - | - | ||||
24.31 | +53.56% | 4 | |||||||
545.00 | +6.55% | 2 | |||||||
- | - | 4.662 | +44.04% | 1 | |||||
22.78 | +40.34% | 9 | |||||||
- | - | - | - | - | - | ||||
- | 9.050 | +8.25% | 6 | ||||||
- | - | 40.00 | -24.10% | 1 | |||||
24.00 | +39.53% | 2 | |||||||
18.67 | +36.85% | 3 | |||||||
Average | 327.99 | +21.81% | 6 | ||||||
Weighted average by Cap. | 457.65 | +16.61% | 9 |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited
- Sector consensus